Characterization of the innate immune response to chronic aspiration in a novel rodent model

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Appel III, James Z ^a   Lee, Sean M ^a   Hartwig, Matthew G ^a   Li, Bin ^a   Hsieh, Chong Chao ^a   Cantu III, Edward ^a   Yoon, Yonghan ^a   Lin, Shu S ^a   Parker, William ^a   Davis, R Duane ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACID ASPIRATION; ANIMAL; ARTICLE; BRONCHIOLITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FISCHER 344 RAT; FLOW CYTOMETRY; GASTROESOPHAGEAL REFLUX; IMMUNOLOGY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; MALE; METABOLISM; PATHOLOGY; RAT; STOMACH ACID;

ANIMALS; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; IMMUNITY, NATURAL; MACROPHAGES, ALVEOLAR; MALE; PULMONARY FIBROSIS; RATS; RATS, INBRED F344; RESPIRATORY ASPIRATION;

EID: 38949178171     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-87     Document Type: Article

References (47)

1. Tobin RW, Pope CE, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 158(6):1804-1808.
2. Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone 2003, 5(4):32-38. discussion 39-40, 10.1016/S1098-3597(03)90097-4, 15101493.
3. Harding SM. Recent clinical investigations examining the association of asthma and gastroesophageal reflux. Am J Med 2003, 115(Suppl 3A):39S-44S. 10.1016/S0002-9343(03)00191-8, 12928073.
4. Ducolone A, Vandevenne A, Jouin H, Grob JC, Coumaros D, Meyer C, Burghard G, Methlin G, Hollender L. Gastroesophageal reflux in patients with asthma and chronic bronchitis. Am Rev Respir Dis 1987, 135(2):327-332.
5. Ledson MJ, Tran J, Walshaw MJ. Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients. J R Soc Med 1998, 91(1):7-9. 1296415, 9536132.
6. Henderson RD, Woolfe CR. Aspiration and gastroesophageal reflux. Can J Surg 1978, 21(4):352-354.
7. Crausaz FM, Favez G. Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease. Chest 1988, 93(2):376-378. 10.1378/chest.93.2.376, 3338306.
8. DeMeester TR, Bonavina L, Iascone C, Courtney JV, Skinner DB. Chronic respiratory symptoms and occult gastroesophageal reflux. A prospective clinical study and results of surgical therapy. Ann Surg 1990, 211(3):337-345. 1358440, 2310240, 10.1097/00000658-199003000-00005.
9. Cantu E, Appel JZ, Hartwig MG, Woreta H, Green C, Messier R, Palmer SM, Davis RD. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004, 78(4):1142-1151. discussion 1142-1151, 10.1016/j.athoracsur.2004.04.044, 15464462.
10. Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003, 17(4):363-368. 10.1034/j.1399-0012.2003.00060.x, 12868994.
11. Davis RD, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, Palmer SM. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003, 125(3):533-542. 10.1067/mtc.2003.166, 12658195.
12. Lau CL, Palmer SM, Howell DN, McMahon R, Hadjiliadis D, Gaca J, Pappas TN, Davis RD, Eubanks S. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 2002, 16(12):1674-1678. 10.1007/s00464-001-8251-2, 12140642.
13. Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000, 118(4):1214-1217. 10.1378/chest.118.4.1214, 11035701.
14. Hartwig M, Appel JZ, Cantu E, Woreta H, Palmer SM, Davis RD. Non-alloimmune Injury Mediated by Gastroesophageal Reflux Precipitates Alloimmune Injury in Lung Transplant Patients. J Heart Lung Transplant 23(2):s43.
15. Knight PR, Rutter T, Tait AR, Coleman E, Johnson K. Pathogenesis of gastric particulate lung injury: a comparison and interaction with acidic pneumonitis. Anesth Analg 1993, 77(4):754-760. 10.1213/00000539-199310000-00017, 8214660.
16. Kennedy TP, Johnson KJ, Kunkel RG, Ward PA, Knight PR, Finch JS. Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesth Analg 1989, 69(1):87-92.
17. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988, 41(4):467-470. 1141479, 3366935, 10.1136/jcp.41.4.467.
18. Teabeaut JR. Aspiration of gastric contents; an experimental study. Am J Pathol 1952, 28(1):51-67. 1937292, 14885406.
19. Duncan SR, Leonard C, Theodore J, Lega M, Girgis RE, Rosen GD, Theofilopoulos AN. Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 2002, 165(10):1439-1444. 10.1164/rccm.2107009, 12016109.
20. Reynaud-Gaubert M, Thomas P, Gregoire R, Badier M, Cau P, Sampol J, Giudicelli R, Fuentes P. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients. Eur J Cardiothorac Surg 2002, 21(1):60-66. 10.1016/S1010-7940(01)01068-5, 11788258.
21. Kirk A. Immunology of Transplantation. Surgery: Basic Science and Clinical Evidence 2001, New York: Springer-Verlag, Norton J, Bollinger RR, Chang AE, Lowry SE, Mulvihill SJ, Pass HI, Tohmpson RW.
22. Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today 2000, 21(3):110-113. 10.1016/S0167-5699(99)01573-X, 10689296.
23. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998, 391(6669):799-803. 10.1038/35876, 9486651.
24. Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses. Curr Opin Immunol 1998, 10(6):607-613. 10.1016/S0952-7915(98)80077-0, 9914218.
25. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998, 282(5397):2258-2261. 10.1126/science.282.5397.2258, 9856949.
26. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326(5):298-304.
27. Boehler A, Bai XH, Liu M, Cassivi S, Chamberlain D, Slutsky AS, Keshavjee S. Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med 1999, 159(6):1910-1917.
28. Zuo XJ, Matsumura Y, Prehn J, Saito R, Marchevesky A, Matloff J, Jordan SC. Cytokine gene expression in rejecting and tolerant rat lung allograft models: analysis by RT-PCR. Transpl Immunol 1995, 3(2):151-161. 10.1016/0966-3274(95)80042-5, 7582906.
29. Gu Y, Takao M, Kai M, Lu L, Shimamoto A, Onoda K, Shimono T, Tanaka K, Shimpo H, Shiraishi T, et al. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model. Ann Thorac Cardiovasc Surg 2000, 6(4):224-231.
30. Sundaresan S, Alevy YG, Steward N, Tucker J, Trulock EP, Cooper JD, Patterson GA, Mohanakumar T. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts. J Heart Lung Transplant 1995, 14(3):512-518.
31. Jordan SC, Marchevski A, Ross D, Toyoda M, Waters PF. Serum interleukin-2 levels in lung transplant recipients: correlation with findings on transbronchial biopsy. J Heart Lung Transplant 1992, 11(5):1001-1004.
32. Nickerson P, Steiger J, Zheng XX, Steele AW, Steurer W, Roy-Chaudhury P, Strom TB. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance?. Transplantation 1997, 63(4):489-494. 10.1097/00007890-199702270-00001, 9047139.
33. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000, 342(18):1350-1358. 10.1056/NEJM200005043421807, 10793168.
34. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, Campbell C, Rahman A, Sheldon S, Deiraniya A, et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999, 18(9):828-837. 10.1016/S1053-2498(99)00047-9, 10528744.
35. Charpin JM, Valcke J, Kettaneh L, Epardeau B, Stern M, Israel-Biet D. Peaks of transforming growth factor-beta mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation 1998, 65(5):752-755. 10.1097/00007890-199803150-00027, 9521216.
36. Magnan A, Mege JL, Reynaud M, Thomas P, Capo C, Garbe L, Meric B, Badier M, Bongrand P, Viard L, et al. Monitoring of alveolar macrophage production of tumor necrosis factor-alpha and interleukin-6 in lung transplant recipients. Marseille and Montreal Lung Transplantation Group. Am J Respir Crit Care Med 1994, 150(3):684-689.
37. Steinmuller C, Steinhoff G, Bauer D, You XM, Denzin H, Franke-Ullmann G, Hausen B, Bruggemann C, Wagner TO, Lohmann-Matthes ML, et al. Analysis of leukocyte activation during acute rejection of pulmonary allografts in noninfected and cytomegalovirus-infected rats. J Leukoc Biol 1997, 61(1):40-49.
38. Smith CR, Jaramillo A, Lu KC, Higuchi T, Kaleem Z, Mohanakumar T. Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor. Transplantation 2001, 72(9):1512-1518. 10.1097/00007890-200111150-00007, 11707738.
39. Liu M, Suga M, Maclean AA, St George JA, Souza DW, Keshavjee S. Soluble transforming growth factor-beta type III receptor gene transfection inhibits fibrous airway obliteration in a rat model of Bronchiolitis obliterans. Am J Respir Crit Care Med 2002, 165(3):419-423.
40. Farivar AS, Mackinnon-Patterson B, Woolley S, Namkung J, Shimamoto A, Verrier ED, Mulligan MS. FR167653 reduces obliterative airway disease in rats. J Heart Lung Transplant 2004, 23(8):985-992. 10.1016/j.healun.2004.04.008, 15312829.
41. Vaneker M, Halbertsma FJ, van Egmond J, Netea MG, Dijkman HB, Snijdelaar DG, Joosten LA, van der Hoeven JG, Scheffer GJ. Mechanical ventilation in healthy mice induces reversible pulmonary and systemic cytokine elevation with preserved alveolar integrity: an in vivo model using clinical relevant ventilation settings. Anesthesiology 2007, 107(3):419-426. 10.1097/01.anes.0000278908.22686.01, 17721244.
42. Carone FA, Cooke RE. Effect of potassium deficiency on gastric secretion in the rat. The American journal of physiology 1953, 172(3):684-688.
43. Lozzio BB, Biempica L, Royer M, Gorodisch S. Action of aminoguanidine on the stomach of pylorus-ligated rats. The American journal of digestive diseases 1961, 6:534-545. 10.1007/BF02231073, 13763911.
44. Kotani T, Murashima Y, Kobata A, Amagase K, Takeuchi K. Pathogenic importance of pepsin in ischemia/reperfusion-induced gastric injury. Life sciences 2007, 80(21):1984-1992. 10.1016/j.lfs.2007.02.041, 17395212.
45. Campbell NB, Ruaux CG, Shifflett DE, Steiner JM, Williams DA, Blikslager AT. Physiological concentrations of bile salts inhibit recovery of ischemic-injured porcine ileum. American journal of physiology 2004, 287(2):G399-407.
46. Nikula KJ, Green FH. Animal models of chronic bronchitis and their relevance to studies of particle-induced disease. Inhal Toxicol 2000, 12(Suppl 4):123-153. 10.1080/089583700750019549, 12881890.
47. D'Ovidio F, Mura M, Ridsdale R, Takahashi H, Waddell TK, Hutcheon M, Hadjiliadis D, Singer LG, Pierre A, Chaparro C, et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 2006, 6(8):1930-1938. 10.1111/j.1600-6143.2006.01357.x, 16889547.